Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 58 checked references that resolve
resolves10.1101/002824HTSeq – A Python framework to work with high-throughput sequencing data
resolves10.1038/nrc1014Neuroblastoma: biological insights into a clinical enigma
resolves10.1042/bj20081834High incidence of DNA mutations and gene amplifications of the
<i>ALK</i>
gene in advanced sporadic neuroblastoma tumours
resolves10.1073/pnas.0910684107High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
resolves10.1242/dmm.010348Cell culture and
<i>Drosophila</i>
model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma
resolves10.1136/jclinpath-2019-206063The prognostic roles of and correlation between <i>ALK</i> and <i>MYCN</i> protein expression in neuroblastoma
resolves10.1186/1471-2164-5-70cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma
resolves10.1016/j.neuro.2008.11.001Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research
resolves10.1097/00001756-200310270-00011Differential effects of 9-cis, 13-cis and all-trans retinoic acids on the neuronal differentiation of human neuroblastoma cells
resolves10.1073/pnas.1012351108RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma
resolves10.1200/jco.1996.14.1.25Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas.
resolves10.1158/1078-0432.ccr-09-2660Meta-analysis of Neuroblastomas Reveals a Skewed
<i>ALK</i>
Mutation Spectrum in Tumors with
<i>MYCN</i>
Amplification
resolves10.1126/scisignal.2005769Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation
resolves10.1038/24179The murine gene p27Kip1 is haplo-insufficient for tumour suppression
resolves10.1101/mcs.a002550Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib
resolves10.18632/oncotarget.17146Clinical and biological features of neuroblastic tumors: A comparison of neuroblastoma and ganglioneuroblastoma
resolves10.1101/gad.929901<i>Dmp1</i> is haplo-insufficient for tumor suppression and modifies the frequencies of <i>Arf</i> and <i>p53</i> mutations in <i>Myc</i>-induced lymphomas
resolves10.1093/database/bav095RegNetwork: an integrated database of transcriptional and post-transcriptional regulatory networks in human and mouse
resolves10.1074/jbc.270.42.24725Selective Regulation of TrkA and TrkB Receptors by Retinoic Acid and Interferon-γ in Human Neuroblastoma Cell Lines
resolves10.1007/s12325-012-0047-3Retinoids in Pediatric Onco-Hematology: the Model of Acute Promyelocytic Leukemia and Neuroblastoma
resolves10.1200/jco.2007.13.8925Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-<i>cis</i>-Retinoic Acid: A Children's Oncology Group Study
resolves10.1056/nejm199910143411601Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-<i>cis</i>-Retinoic Acid
resolves10.1016/j.euprot.2017.06.001Quantitative proteomic analysis identifies proteins and pathways related to neuronal development in differentiated SH-SY5Y neuroblastoma cells
resolves10.1016/j.ccell.2014.09.014The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation
resolves10.1002/pbc.24433Children's Oncology Group's 2013 blueprint for research: Neuroblastoma
resolves10.1016/j.canlet.2015.09.010Corrigendum to “The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro” [Cancer Lett 364 (2015) 142–155]
resolves10.1111/j.1742-4658.2012.08729.xThe <scp>PDZ</scp> protein discs‐large (<scp>DLG</scp>): the ‘<scp>J</scp>ekyll and <scp>H</scp>yde’ of the epithelial polarity proteins
resolves10.1210/en.2005-0467Insulin-Like Growth Factor Binding Protein-2 Binding to Extracellular Matrix Plays a Critical Role in Neuroblastoma Cell Proliferation, Migration, and Invasion
resolves10.1126/science.1222369The Dorsal Aorta Initiates a Molecular Cascade That Instructs Sympatho-Adrenal Specification
resolves10.1002/mpo.10313FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high‐risk groups in neuroblastoma
resolves10.1073/pnas.0506580102Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
resolves10.1086/383253Germline Mutations of the Paired–Like Homeobox 2B (PHOX2B) Gene in Neuroblastoma
resolves10.1126/scisignal.aam7550MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)–addicted neuroblastomas
resolves10.1038/ng.3899Neuroblastoma is composed of two super-enhancer-associated differentiation states
resolves10.3389/fonc.2019.00275Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia
resolves10.1016/0092-8674(81)90009-xThe discs-large tumor suppressor gene of Drosophila encodes a guanylate kinase homolog localized at septate junctions
checked 2026-09-13 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.